Internal Medicine · San Leandro, CA
NPI
1184801482
Since 2008
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
2500 Merced St
San Leandro, CA, 94577
Phone (510) 454-1000
Groups this clinician bills Medicare through
Medicare paid, 2024
$49K
38,212 services
Medicare patients, 2024
15
Average age 66
Drug cost, 2024
$2.1M
933 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Deepa R Reddy prescribed most often to Medicare patients was Nivestym (Filgrastim-Aafi), with 92 prescriptions and refills. In total Deepa R Reddy wrote 933 Medicare prescriptions that cost $2.1M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-14.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Nivestym Filgrastim-Aafi | 92 | 92 | 13 | $74K |
| Ondansetron Hcl Generic | 90 | 91 | 50 | $752 |
| Imatinib Mesylate Generic | 47 | 55 | Under 11 | $2,971 |
| Prochlorperazine Maleate Generic | 47 | 47 | 32 | $710 |
| Potassium Chloride Generic | 39 | 51 | 13 | $702 |
| Lonsurf Trifluridine/Tipiracil Hcl | 36 | 36 | Under 11 | $326K |
| Anastrozole Generic | 32 | 93 | 12 | $834 |
| Brukinsa Zanubrutinib | 31 | 31 | Under 11 | $399K |
| Prednisone Generic | 30 | 32 | 18 | $221 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 28 | 28 | 17 | $552 |
| Mirtazapine Generic | 28 | 28 | 18 | $205 |
| Ibrance Palbociclib | 25 | 25 | Under 11 | $386K |
| Letrozole Generic | 22 | 47 | Under 11 | $356 |
| Diphenoxylate-Atropine Diphenoxylate Hcl/Atropine | 22 | 22 | 12 | $250 |
| Granix Tbo-Filgrastim | 20 | 20 | Under 11 | $12K |
Brand drugs: - claims; generic drugs: 634 claims; opioid claims: 48.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Deepa R Reddy were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.